Artificial Womb Trials in Humans Could Start Soon
“Researchers at Children’s Hospital of Philadelphia are seeking approval for the first human clinical trials of the device they’ve been testing, named the Extra-uterine Environment for Newborn Development, or EXTEND. The team has emphasized that the technology is not intended — or able — to support development from conception to birth. Instead, the scientists hope that simulating some elements of a natural womb will increase survival and improve outcomes for extremely premature babies. In humans, that’s anything earlier than 28 weeks of gestation — less than 70% of the way to full term, which is typically between 37 and 40 weeks.” (Scientific American)
Elon Musk’s Neuralink begins accepting human patients for trials of its brain implant
“The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) – a groundbreaking investigational medical device trial for our fully-implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for enabling people with paralysis to control external devices with their thoughts. During the study, the R1 Robot will be used to surgically place the N1 Implant’s ultra-fine and flexible threads in a region of the brain that controls movement intention. Once in place, the N1 Implant is cosmetically invisible and is intended to record and transmit brain signals wirelessly to an app that decodes movement intention. The initial goal of our BCI is to grant people the ability to control a computer cursor or keyboard using their thoughts alone.” (Neuralink)
Decarbonizing 8 industrial sectors could require more than $1 trillion capital investment: DOE
“Decarbonizing the U.S. power grid is a “critical” factor in efforts to reduce emissions from the industrial sector, the Department of Energy said in a report published Monday. DOE’s “Pathways to Commercial Liftoff” report examines decarbonization approaches for eight domestic industrial sectors: chemicals, refining, iron and steel, food and beverage processing, pulp and paper, cement, aluminum, and glass. Those sectors accounted for about 14% of U.S. carbon dioxide emissions in 2021, according to the analysis. Progress on eliminating emissions from the U.S. industrial sector “is at risk of lagging other countries and domestic net-zero targets,” the agency warned.” (Utility Dive)
- A Letter from Laura Deming on the Longevity Fund
- NASA delivers bounty of asteroid samples to Earth
- MIT Makes Low-Power Underwater Communication Practical
- Marine Corps orders safety stand-down of all aircraft after F-35 disappearance
- Volvo to cease production of diesel cars in a few months
- Varda Space puts off orbital factory reentry pending Air Force and FAA green light
- RoboFab is ready to build 10,000 humanoid robots per year
- Stoke Space completes milestone test in quest to build a fully reusable rocket
- Beyond Aero is building a hydrogen-powered jet
- Underwater robots have been secured for the US’s first floating offshore wind farm
- AI Tool Pinpoints Genetic Mutations That Cause Disease
- A modern digital light processing technology to 3D print microfluidic chips
- Portable device instantly detects illegal drugs with 95% accuracy
- Machine learning analysis of research citations highlights importance of federal funding for basic scientific research
- RNA has been recovered from an extinct species for the first time
- Researchers advance topological superconductors for quantum computing
- True Anomaly lands $17.4M contract from U.S. Space Force for space domain awareness tech
- Diligent raises $25M to triple its nursing robot’s reach
- $4.6B for climate action plan implementation available from EPA
- TOLREMO therapeutics, a startup looking to prevent non-genetic drug resistance, raised a $39M Series A
- BeDimensional, a startup producing graphene and other 2D crystals, raised $5.3M in funding
- VerImmune, a startup developing a Virus-inspired Particle “ViP” technology platform, raised a $3.1M seed
- Magnet Biomedicine, a biotech company developing molecular glue, raised a $50M round
- Virtual Incision, a developer of a robotic-assisted surgery system, raised a $30M extension to its previously $46M Series C
- RNA editing therapeutics startup Airna raised a $30M round
- Genomics company Broken String Biosciences raised a $15M Series A
- Beckley Waves, a venture studio focused on the psychedelic ecosystem, raised $3.3M
- Defense AI startup Helsing raised a $223M Series B
Skepticism about claim human ancestors nearly went extinct / How can we bring down the costs of large space telescopes? / Why the Next Microgrids Will Be Well Connected / STELLA: NASA’s DIY gadget for measuring plant health / Deepfakes of Chinese influencers are livestreaming 24/7 / Here Come the Glow-in-the-Dark Houseplants / Why We’ll Never Live in Space / Finding Battery Minerals With AI / The Gruesome Story of How Neuralink’s Monkeys Actually Died / European deeptech’s fastest-growing teams / Tesla buys German railway line / Google sued for negligence after man died following map directions / The future of batteries needs more than venture capital / Brainless Jellyfish Demonstrate Learning Ability / She got famous on YouTube. Now it helps fund her research in quantum gravity